基本信息
浏览量:152
职业迁徙
个人简介
He specializes in Hemato-Oncology. His research focuses on drug resistance mechanisms in patients with cancer, chemotherapy and targeted therapy of lung cancer, predictive factors in lung cancer, and anemia management in patients with cancer. As a member of the IALT-Bio and LACE-Bio groups, he has been involved in the characterization of predictive factors with regard to adjuvant chemotherapy in patients with completely resected non-small cell Lung Cancer (NSCLC). He was also the worldwide Co-ordinating Investigator of the First-Line Erbitux in lung cancer (FLEX) trial.
研究兴趣
论文共 444 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
CANCER TREATMENT REVIEWS (2024): 102664-102664
Current Opinion in Oncology (2023)
引用0浏览0引用
0
0
CA: a cancer journal for cliniciansno. 6 (2023): 620-652
引用7浏览0WOS引用
7
0
Current opinion in oncology (2023)
引用0浏览0WOS引用
0
0
Virchows Archiv : an international journal of pathologyno. 1 (2022): 39-51
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn